Loading
PF
PT Famon Awal Bros Sedaya Tbk Stock: price and insider trades · Indonesia
No insider purchase over the last 90 days. The latest, by Yoshen Danun, MBA, was filed 26 May 2025.
PT Famon Awal Bros Sedaya Tbk: what insiders have been doing
Headquartered in Indonesia, PT Famon Awal Bros Sedaya Tbk belongs to the Health Care sector. Filings by its managers are published through OJK / IDX. The past year has been quiet: not a single insider filing for PT Famon Awal Bros Sedaya Tbk. The previous disclosure was published on 26 May 2025.
Looking back to 2024, when coverage begins, insiders filed 3 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from OJK / IDX disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: Indonesia
Source: Wikidata (CC0).
Insider Decl.
3
Thresholds
n/a
Buy Volume
€281,066
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleYos Effendi Susanto1 buy
Yoshen Danun, MBA1 buy
Since the insiders bought
- +16.1%Entry IDR 620.00 · Close at T+365 IDR 720.00
- +33.8%Entry IDR 650.00 · Close at T+365 IDR 870.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,383 of 26,250 companies
35.2
score / 100
Value27
Quality43
FCF yld-4.3%
Earn yld2.3%
EV/EBITDA29.9x
ROE5.5%
Gross mgn28%
Net mgn8.7%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
IDR 665.00
Analyst consensus
1 analystsIDR 1,200.00Target IDR 1,200.00(+80%)IDR 1,200.00
Income statement
RevenueIDR 2.4T
Gross profitIDR 681.2B28% margin
EBITDAIDR 375.7B15% margin
Net incomeIDR 211.4B6.7% margin
Valuation
PER (trailing)50.2x
PER (forward)23.6x
P/Book2.8x
Beta0.35
Balance sheet & cash
Market capIDR 9.3T
Total debtIDR 1.9T
Free Cash Flow-IDR 403.7B
Debt / Equity56%
Profitability & ownership
ROE5.5%
ROA3.0%
% insiders94.6%
% institutions4.7%
Last declaration on 26 May 2025
Declarations3 total
1,700 shares@ IDR 610.00100.0% of flowIDXIDX:018-CorpSec-FABS-V-2025-PRAY#0
Canonical exit: 17 Aug 2025 (T+90)
3,005,400 shares@ IDR 720.00100.0% of flowIDXIDX:002-CorpSec-FABS-I-2025-PRAY#0
Canonical exit: 30 Mar 2025 (T+90)
3,604,200 shares@ IDR 720.0053.9% of flowIDXIDX:001-CorpSec-FABS-I-2024-PRAY#0
Canonical exit: 28 Mar 2024 (T+90)
3 of 3 declarations
About PT Famon Awal Bros Sedaya Tbk
PT Famon Awal Bros Sedaya Tbk is a publicly traded company on the Indonesian Stock Exchange, specializing in the healthcare sector. It provides various medical services and manages several healthcare facilities across Indonesia.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations